文献速递腹部MR

肝细胞癌的LI-RADS v2014分类:钆喷酸葡胺增强MRI与钆塞酸二钠增强MRI的个体内比较

LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.
PubMed 文献 · Eur Radiol · 2018-06-19

在64例患者共77个肝细胞癌中,个体内比较钆喷酸葡胺增强MRI与钆塞酸二钠增强MRI的LI-RADS分类及主要征象,发现后者廓清和包膜表现出现频率更低,LR-5诊断敏感度显著更低;将肝胆期低信号作为附加主要征象或将移行期低信号作为廓清表现可提高敏感度,与钆喷酸葡胺增强MRI相当。

要点

  • 钆塞酸二钠增强MRI上廓清和包膜表现出现频率显著低于钆喷酸葡胺增强MRI。
  • 直接套用LI-RADS v2014于钆塞酸二钠增强MRI时LR-5分类敏感度显著降低。
  • 将肝胆期低信号作为附加主要征象可提高LR-5分类敏感度,与钆喷酸葡胺增强MRI相当。

核心结论

  • 对LI-RADS进行修改以适用于钆塞酸二钠增强MRI,如将肝胆期低信号作为附加主要征象或将移行期低信号作为廓清表现,可提高肝细胞癌检出敏感度。

研究设计与样本

  • 个体内比较研究,64例患者共77个肝细胞癌,其中17个经组织病理学证实,46例患者有肝硬化;两位放射科医师评估钆塞酸二钠增强MRI与钆喷酸葡胺增强MRI的主要及辅助征象,分别进行LI-RADS-DTPA、LI-RADS-EOB及三种修改版(LI-RADS-EOBm1、m2、m3)分类并比较LR-5敏感度。

关键影像表现/征象

  • 钆塞酸二钠增强MRI上廓清表现出现频率低于钆喷酸葡胺增强MRI(p=0.012)。
  • 钆塞酸二钠增强MRI上包膜表现出现频率低于钆喷酸葡胺增强MRI(p<0.001)。

诊断标准与关键数值

  • LI-RADS-DTPA的LR-5分类敏感度显著高于LI-RADS-EOB(p=0.001)。
  • LI-RADS-DTPA的LR-5分类敏感度显著高于LI-RADS-EOBm2(p=0.004)。
  • LI-RADS-EOBm1的LR-5分类敏感度与LI-RADS-DTPA相当(p=0.210)。
  • LI-RADS-EOBm3的LR-5分类敏感度与LI-RADS-DTPA相当(p=0.727)。
  • 修改版主要征象定义:LI-RADS-EOBm1将肝胆期低信号作为附加主要征象,LI-RADS-EOBm2将肝胆期低信号环作为包膜表现,LI-RADS-EOBm3将移行期低信号作为廓清表现。

临床应用与阅片要点

  • 在钆塞酸二钠增强MRI上应用LI-RADS v2014时,需注意廓清和包膜表现出现频率低于钆喷酸葡胺增强MRI,可能影响LR-5分类。
  • 作者结论提示,将肝胆期低信号作为附加主要征象或将移行期低信号作为廓清表现,可提高LR-5分类对肝细胞癌的检出敏感度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To use Liver Imaging Reporting and Data System (LI-RADS) categorization and features of hepatocellular carcinomas (HCCs) to intraindividually compare gadopentetate dimeglumine-enhanced magnetic resonance imaging (Gd-DTPA-MRI) and gadoxetic acid-enhanced MRI (Gd-EOB-MRI), before and after applying modified major features.

METHODS: Of 77 HCCs in 64 patients analysed, 17 HCCs were confirmed histopathologically and 46 patients had cirrhosis. Gd-EOB-MRI and Gd-DTPA-MRI were evaluated for the presence of major and ancillary features by two radiologists. LI-RADS categorization was done for Gd-DTPA-MRI (LI-RADS-DTPA) and for Gd-EOB-MRI before and after applying modified major features (hepatobiliary phase [HBP] hypointensity as an additional major feature, LI-RADS-EOBm1; HBP hypointense rim as capsule appearance, LI-RADS-EOBm2; and transitional phase [TP] hypointensity as washout appearance, LI-RADS-EOBm3). Sensitivities of LR-5 categorization for the diagnosis of HCC were compared.

RESULTS: Washout (p=0.012) and capsule appearance (p<0.001) were less frequently observed on Gd-EOB-MRI. Sensitivity for LR-5 categorization was significantly higher with LI-RADS-DTPA compared with LI-RADS-EOB (p=0.001) and LI-RADS-EOBm2 (p=0.004), while sensitivity for LR-5 categorization with LI-RADS-EOBm1 (p=0.210) and LI-RADS-EOBm3 (p=0.727) was comparable.

CONCLUSION: Modifying LI-RADS for use with Gd-EOB-MRI, such as applying HBP hypointensity as an additional major feature or using TP hypointensity as washout appearance, can improve the sensitivity for the detection of HCC.

KEY POINTS: • Adding HBP hypointensity as additional major feature improved sensitivity of LR-5 categorization. • Adding TP hypointensity as modified washout appearance improved sensitivity of LR-5 categorization. • Sensitivities for LR-5 classification were comparable between LI-RADS-DTPA, LI-RADS-EOBm1, and LI-RADS-EOBm3.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Song JS, Choi EJ, Hwang SB, et al. LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI. Eur Radiol. 2018. PMID: 29922928. doi:10.1007/s00330-018-5559-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。